A Weight-Loss Plateau on a GLP-1: Questions for Your Clinician

Which symptoms mean you should call a clinician instead of waiting?

A stall on the scale is not an emergency. Some symptoms are, and they matter more than your pace.

• Severe or persistent stomach pain, sometimes spreading to your back, with or without vomiting. The Wegovy and Zepbound labels describe these as the symptoms of acute pancreatitis, and both direct patients to contact their healthcare provider if it is suspected. 1 2
• Nausea, vomiting, or diarrhea that leaves you dehydrated. Both labels report acute kidney injury in people whose stomach side effects led to dehydration. 1 2
• Upper-abdominal pain, fever, yellowing of the skin or eyes, or clay-colored stools. Both labels warn about gallbladder disease. 1 2

Call your prescriber the same day for any of these, or seek emergency care if symptoms are severe. Nothing on this page tells you your own symptoms are harmless; only a clinician who knows your history can assess them. If you cannot eat or keep fluids down, that is a reason to call regardless of what the scale says.

What does a plateau on a GLP-1 look like in the trials?

In the published trial figures, the average weight curves fall steeply at first and then level off. In the Zepbound label's Study 1 figure, the 5 mg, 10 mg, and 15 mg curves bend toward flat over the final months, ending at −16.1%, −20.9%, and −22.0% observed at week 72, while the placebo curve is flat much earlier. 2 The Wegovy label's weight curves for its 68-week studies also flatten toward the end of the study period. 1

Two limits matter. First, these are averages across hundreds of people; they do not show whether any one person's path was smooth, stepped, or flat. Second, neither label defines a plateau, sets a number of weeks that counts as one, or says what a stall means for an individual. The evidence does not settle those questions, so be wary of any page that claims it does.

If your weight has barely moved in a few weeks, that can fit the pattern of the curves. It can also fit something else, which is why it is a question for your prescriber.

How is a plateau different from slow progress at the start?

Slow progress in the first months is partly a matter of timing: the trials measured results at 68 and 72 weeks, after months of dose escalation. We cover that in why weight loss on a GLP-1 may be slower than expected. A plateau is a different question: you made progress, and it stopped.

NIDDK's checkpoint is also about a different situation. It says that if you are not losing weight after 12 weeks on the full dose, you should ask your health care professional whether to stop, and that someone who does not lose at least 5% of starting weight in that time will probably be advised to stop. 3 That describes someone who has not responded, not someone who responded and then stalled. Either way, NIDDK frames it as a decision with your health care professional, and it adds that they may also change your treatment plan, try a different medication, or adjust other medicines that could be affecting weight. 3

What can a clinician look at when weight stops moving?

This table is our own arrangement of questions, not a diagnosis tool. It shows what a prescriber may check and what you can bring to help.

What may be checked	What to bring
How long you have been at your current dose, and whether recent dose changes were planned	Your dose history as your prescriber gave it, with dates
Whether the measurements are comparable	Weights taken the same way, at the same time of day, on the dates your care team asked for
Whether you are eating enough and getting enough protein	A few honest days of what you ate, including appetite changes
Side effects that limit eating, drinking, or moving	A note of when they happen and how long they last
Other medicines or supplements that can affect weight	Your complete list, including anything new
Sleep, stress, recent illness, or surgery	Dated notes of any change
Changes in activity and strength	What you do in a typical week; see GLP-1s and muscle loss
Hormonal or other health changes in midlife	Symptoms you have noticed, kept separate from weight; see HRT and GLP-1 treatment

A weight that holds steady while your clothes fit differently, or while your strength and energy change, is not the same as no change. Mention both to your prescriber; they can say what it means for your goals.

What should you not do to break a plateau?

• Do not change your dose or timing yourself. Dosing belongs to your prescriber and your product's instructions. 1 2
• Do not add products to push the scale. Talk with your health care professional about any other medications, supplements, or vitamins. 3
• Do not cut food sharply on your own. Ask your prescriber what amount of eating is right for you. If appetite has dropped so far that eating feels hard, tell them.
• Do not stop on your own. NIDDK says you probably will regain some weight after you stop a weight management medication. 3 Talk first.
• Do not assume compounded and approved products behave alike. The curves above come from approved branded products and do not transfer to a compounded preparation, which is not FDA-approved. Our guide to compounded versus brand-name GLP-1s explains the difference.

How can you keep a four-week log before your visit?

A log gives your prescriber a trend. It is a way to prepare for a conversation, not a plan for self-treatment.

1. Write down your dose and the date of your last injection or dose, exactly as your prescriber gave them.
2. Record weight only as often as your care team asked, using the same method each time.
3. Note once a week how your appetite, energy, sleep, and digestion feel.
4. Note anything that changed: new medicine, illness, travel, a new exercise routine, or a stressful stretch.
5. Write down two or three questions you want answered.

Our guide to preparing for your follow-up appointment covers the rest of the visit, and what a GLP-1 care plan should include describes what support to expect between visits. If you are newer to treatment, our first 90 days planner is the best starting point.

What should you ask your clinician?

• How long have I been at my current dose, and what is the plan from here?
• Does what I have recorded look like a plateau, or is something else going on?
• Could a medicine, a health condition, sleep, or a life change be involved?
• Am I eating enough, and enough protein, for the way I am training and living?
• What would we look at next, and when will we review whether treatment is working for me?
• If it is not working well, what are the options, and what would each change in cost and care?

If you are paying for care yourself, ask the last question before you agree to a change, so you can compare options on the same terms.

Common questions

Is a plateau a sign the medicine has stopped working?

Not necessarily. The trial curves flatten on average, and a stall can have other causes. Only your prescriber, with your history in front of them, can say what it means for you.

How long is a plateau supposed to last?

The labels do not say. They report averages and do not define plateau length, so a number from another source would be a guess.

Will a higher dose get me moving again?

That is a prescribing decision. Ask your prescriber about your plan, and do not raise your dose yourself.

Does a plateau mean I should stop treatment?

NIDDK describes stopping as a decision between you and your health care professional, based on how the medication is working and whether side effects are serious. 3 Do not make it alone.